Artificial Intelligence and Radiomics to Predict Hepatocellular Carcinoma Risk in Cirrhosis Patients
Posted Date:
Jul 13, 2026
Jul 23, 2026
Awarded Date:
No Awarded Date
| SetAside Type | ||
| No Set aside used | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N98026Q00779 | Artificial Intelligence and Radiomics to Predict Hepatocellular Carcinoma Risk in Cirrhosis Patients | |
| Synopsis | ||
|
The mission of the National Institute of Diabetes and Digestive and Kidney Diseases is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases to improve people’s health and quality of life. The Liver Diseases Branch is conducting research using radiographic imaging and artificial intelligence to evaluate liver cancer risk in patients with advanced liver disease or cirrhosis. Funding for this effort was awarded through the Bench-to-Bedside and Back Award Program (Award Number 1517448). A .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
